1. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics. 2006. 26:553–580.
2. Hughes MJ, Fisher C, Sohaib SA. Imaging features of primary nonurachal adenocarcinoma of the bladder. AJR Am J Roentgenol. 2004. 183:1397–1401.
3. Michels J, Barbour S, Cavers D, Chi KN. Metastatic signet-ring cell cancer of the bladder responding to chemotherapy with capecitabine: case report and review of literature. Can Urol Assoc J. 2010. 4:E55–E57.
4. Busto Martín LA, Janeiro Pais M, González Dacal J, Chantada Abal V, Busto Castañón L. Signet-ring cell adenocarcinoma of the bladder: case series between 1990-2009. Arch Esp Urol. 2010. 63:150–153.
5. Shanks JH, Iczkowski KA. Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics. Histopathology. 2009. 54:885–900.
6. Abol-Enein H, Kava BR, Carmack AJ. Nonurothelial cancer of the bladder. Urology. 2007. 69:93–104.
7. Kundra V, Silverman PM. Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder. AJR Am J Roentgenol. 2003. 180:1045–1054.
8. Anderström C, Johansson SL, von Schultz L. Primary adenocarcinoma of the urinary bladder. A clinicopathologic and prognostic study. Cancer. 1983. 52:1273–1280.
9. Fischer CG, Waechter W, Kraus S, Fuentecilla Perez E, Weidner W, Dudeck J. Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries. Cancer. 1998. 82:775–783.